Genetics of coronary artery disease: Genome-wide association studies and beyond

Atherosclerosis

Volumn 225, Issue 1, 2012, Pages 1-10

  Prins, Bram P ^a   Lagou, Vasiliki ^a,b   Asselbergs, Folkert W ^c   Snieder, Harold ^a   Fu, Jingyuan ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Coronary artery disease; Genome wide association study; Heritability; Systems genetics

Indexed keywords

CORONARY ARTERY DISEASE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HERITABILITY; HUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

CORONARY ARTERY DISEASE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEOMICS; QUANTITATIVE TRAIT LOCI; RISK; SYSTEMS BIOLOGY;

EID: 84867839391     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.05.015     Document Type: Review

References (95)

1. Roger V.L., Go A.S., Lloyd-Jones D.M., et al. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 2011, 123:e18-e209.
2. Marenberg M.E., Risch N., Berkman L.F., et al. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 1994, 330:1041-1046.
3. Schildkraut J.M., Myers R.H., Cupples L.A., et al. Coronary risk associated with age and sex of parental heart disease in the Framingham Study. Am J Cardiol 1989, 64:555-559.
4. Zdravkovic S., Wienke A., Pedersen N.L., et al. Heritability of death from coronary heart disease: a 36-year follow-up of 20 966 Swedish twins. J Intern Med 2002, 252:247-254.
5. Liu H., Liu W., Liao Y., et al. CADgene: a comprehensive database for coronary artery disease genes. Nucleic Acids Res 2011, 39:D991-D996.
6. Ozaki K., Inoue K., Sato H., et al. Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin-alpha secretion in vitro. Nature 2004, 429:72-75.
7. Ozaki K., Ohnishi Y., Iida A., et al. Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat Genet 2002, 32:650-654.
8. Kimura A., Takahashi M., Choi B.Y., et al. Lack of association between LTA and LGALS2 polymorphisms and myocardial infarction in Japanese and Korean populations. Tissue Antigens 2007, 69:265-269.
9. Ozaki K., Sato H., Inoue K., et al. SNPs in BRAP associated with risk of myocardial infarction in Asian populations. Nat Genet 2009, 41:329-333.
10. Takeuchi F., Yokota M., Yamamoto K., et al. Genome-wide association study of coronary artery disease in the Japanese. Eur J Hum Genet 2011, 20:333-340.
11. Tregouet D.A., Konig I.R., Erdmann J., et al. Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease. Nat Genet 2009, 41:283-285.
12. Kathiresan S., Voight B.F., Purcell S., et al. Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet 2009, 41:334-341.
13. Erdmann J., Grosshennig A., Braund P.S., et al. New susceptibility locus for coronary artery disease on chromosome 3q22.3. Nat Genet 2009, 41:280-282.
14. Samani N.J., Erdmann J., Hall A.S., et al. Genomewide association analysis of coronary artery disease. N Engl J Med 2007, 357:443-453.
15. McPherson R., Pertsemlidis A., Kavaslar N., et al. A common allele on chromosome 9 associated with coronary heart disease. Science 2007, 316:1488-1491.
16. Helgadottir A., Thorleifsson G., Manolescu A., et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 2007, 316:1491-1493.
17. Ioannidis J.P. Prediction of cardiovascular disease outcomes and established cardiovascular risk factors by genome-wide association markers. Circ Cardiovasc Genet 2009, 2:7-15.
18. Humphries S.E., Drenos F., Ken-Dror G., et al. Coronary heart disease risk prediction in the era of genome-wide association studies: current status and what the future holds. Circulation 2010, 121:2235-2248.
19. Clarke R., Peden J.F., Hopewell J.C., et al. Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N Engl J Med 2009, 361:2518-2528.
20. Schunkert H., Konig I.R., Kathiresan S., et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet 2011, 43:333-338.
21. Wang F., Xu C.Q., He Q., et al. Genome-wide association identifies a susceptibility locus for coronary artery disease in the Chinese Han population. Nat Genet 2011, 43:345-349.
22. Erdmann J., Willenborg C., Nahrstaedt J., et al. Genome-wide association study identifies a new locus for coronary artery disease on chromosome 10p11.23. Eur Heart J 2011, 32:158-168.
23. Reilly M.P., Li M., He J., et al. Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies. Lancet 2011, 377:383-392.
24. Davies R.W., Wells G.A., Stewart A.F., et al. A genome-wide association study for coronary artery disease identifies a novel susceptibility locus in the major histocompatibility complex. Circ Cardiovasc Genet 2012, 5:217-225.
25. The Coronary Artery Disease (C4D) Genetics Consortium A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease. Nat Genet 2011, 43:339-344.
26. Barbalic M., Reiner A.P., Wu C., et al. Genome-wide association analysis of incident coronary heart disease (CHD) in African Americans: a short report. PLoS Genet 2011, 7. e1002199.
27. Wild P.S., Zeller T., Schillert A., et al. A genome-wide association study identifies LIPA as a susceptibility gene for coronary artery disease. Circ Cardiovasc Genet 2011, 4:403-412.
28. Keating B.J., Tischfield S., Murray S.S., et al. Concept, design and implementation of a cardiovascular gene-centric 50 k SNP array for large-scale genomic association studies. PLoS One 2008, 3. e3583.
29. Visscher P.M., Hill W.G., Wray N.R. Heritability in the genomics era-concepts and misconceptions. Nat Rev Genet 2008, 9:255-266.
30. Bansal V., Libiger O., Torkamani A., et al. Statistical analysis strategies for association studies involving rare variants. Nat Rev Genet 2010, 11:773-785.
31. Cirulli E.T., Goldstein D.B. Uncovering the roles of rare variants in common disease through whole-genome sequencing. Nat Rev Genet 2010, 11:415-425.
32. Manolio T.A., Collins F.S., Cox N.J., et al. Finding the missing heritability of complex diseases. Nature 2009, 461:747-753.
33. McCarroll S.A. Extending genome-wide association studies to copy-number variation. Hum Mol Genet 2008, 17:R135-R142.
34. Eichler E.E., Flint J., Gibson G., et al. Missing heritability and strategies for finding the underlying causes of complex disease. Nat Rev Genet 2010, 11:446-450.
35. Wray N.R., Goddard M.E., Visscher P.M. Prediction of individual genetic risk to disease from genome-wide association studies. Genome Res 2007, 17:1520-1528.
36. Park J.H., Wacholder S., Gail M.H., et al. Estimation of effect size distribution from genome-wide association studies and implications for future discoveries. Nat Genet 2010, 42:570-575.
37. Preuss M., Konig I.R., Thompson J.R., et al. Design of the coronary ARtery DIsease genome-wide replication and meta-analysis (CARDIoGRAM) study: a genome-wide association meta-analysis involving more than 22 000 cases and 60 000 controls. Circ Cardiovasc Genet 2010, 3:475-483.
38. Rhoads G.G., Dahlen G., Berg K., et al. Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA 1986, 256:2540-2544.
39. Snieder H., van Doornen L.J., Boomsma D.I. The age dependency of gene expression for plasma lipids, lipoproteins, and apolipoproteins. Am J Hum Genet 1997, 60:638-650.
40. Snieder H., van Doornen L.J., Boomsma D.I. Dissecting the genetic architecture of lipids, lipoproteins, and apolipoproteins: lessons from twin studies. Arterioscler Thromb Vasc Biol 1999, 19:2826-2834.
41. Beekman M., Heijmans B.T., Martin N.G., et al. Two-locus linkage analysis applied to putative quantitative trait loci for lipoprotein(a) levels. Twin Res 2003, 6:322-324.
42. Boerwinkle E., Leffert C.C., Lin J., et al. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest 1992, 90:52-60.
43. Falchi M., Andrew T., Snieder H., et al. Identification of QTLs for serum lipid levels in a female sib-pair cohort: a novel application to improve the power of two-locus linkage analysis. Hum Mol Genet 2005, 14:2971-2979.
44. Lanktree M.B., Hegele R.A. Gene-gene and gene-environment interactions: new insights into the prevention, detection and management of coronary artery disease. Genome Med 2009, 1:28.
45. Kivimaki M., Magnussen C.G., Juonala M., et al. Conventional and Mendelian randomization analyses suggest no association between lipoprotein(a) and early atherosclerosis: the Young Finns Study. Int J Epidemiol 2011, 40:470-478.
46. Iyengar S.K., Elston R.C. The genetic basis of complex traits: rare variants or "common gene, common disease"?. Methods Mol Biol 2007, 376:71-84.
47. Pritchard J.K. Are rare variants responsible for susceptibility to complex diseases?. Am J Hum Genet 2001, 69:124-137.
48. Gorlov I.P., Gorlova O.Y., Sunyaev S.R., et al. Shifting paradigm of association studies: value of rare single-nucleotide polymorphisms. Am J Hum Genet 2008, 82:100-112.
49. Lage K., Karlberg E.O., Storling Z.M., et al. A human phenome-interactome network of protein complexes implicated in genetic disorders. Nat Biotechnol 2007, 25:309-316.
50. Zhu X., Feng T., Li Y., et al. Detecting rare variants for complex traits using family and unrelated data. Genet Epidemiol 2010, 34:171-187.
51. Sebat J., Lakshmi B., Troge J., et al. Large-scale copy number polymorphism in the human genome. Science 2004, 305:525-528.
52. Bochukova E.G., Huang N., Keogh J., et al. Large, rare chromosomal deletions associated with severe early-onset obesity. Nature 2010, 463:666-670.
53. Kraft H.G., Lingenhel A., Kochl S., et al. Apolipoprotein(a) kringle IV repeat number predicts risk for coronary heart disease. Arterioscler Thromb Vasc Biol 1996, 16:713-719.
54. Stangl K., Cascorbi I., Laule M., et al. High CA repeat numbers in intron 13 of the endothelial nitric oxide synthase gene and increased risk of coronary artery disease. Pharmacogenetics 2000, 10:133-140.
55. Yuan G., Wang J., Hegele R.A. Heterozygous familial hypercholesterolemia: an underrecognized cause of early cardiovascular disease. CMAJ 2006, 174:1124-1129.
56. Craddock N., Hurles M.E., Cardin N., et al. Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature 2010, 464:713-720.
57. Kwon H.J., Lagace T.A., McNutt M.C., et al. Molecular basis for LDL receptor recognition by PCSK9. Proc Natl Acad Sci U S A 2008, 105:1820-1825.
58. Cordell H.J. Detecting gene-gene interactions that underlie human diseases. Nat Rev Genet 2009, 10:392-404.
59. Peng G., Luo L., Siu H., et al. Gene and pathway-based second-wave analysis of genome-wide association studies. Eur J Hum Genet 2010, 18:111-117.
60. Sabatti C., Service S.K., Hartikainen A.L., et al. Genome-wide association analysis of metabolic traits in a birth cohort from a founder population. Nat Genet 2009, 41:35-46.
61. Baccarelli A., Tarantini L., Wright R.O., et al. Repetitive element DNA methylation and circulating endothelial and inflammation markers in the VA normative aging study. Epigenetics 2010, 5.
62. Feinberg A.P., Irizarry R.A. Evolution in health and medicine Sackler colloquium: stochastic epigenetic variation as a driving force of development, evolutionary adaptation, and disease. Proc Natl Acad Sci U S A 2010, 107(Suppl. 1):1757-1764.
63. Kong A., Steinthorsdottir V., Masson G., et al. Parental origin of sequence variants associated with complex diseases. Nature 2009, 462:868-874.
64. Castro R., Rivera I., Struys E.A., et al. Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease. Clin Chem 2003, 49:1292-1296.
65. Kim M., Long T.I., Arakawa K., et al. DNA methylation as a biomarker for cardiovascular disease risk. PLoS One 2010, 5. e9692.
66. Sharma P., Kumar J., Garg G., et al. Detection of altered global DNA methylation in coronary artery disease patients. DNA Cell Biol 2008, 27:357-365.
67. Nadeau J.H., Dudley A.M., Genetics Systems genetics. Science 2011, 331:1015-1016.
68. Morris M.R., Ricketts C.J., Gentle D., et al. Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma. Oncogene 2011, 30:1390-1401.
69. Staal F.J., de Ridder D., Szczepanski T., et al. Genome-wide expression analysis of paired diagnosis-relapse samples in ALL indicates involvement of pathways related to DNA replication, cell cycle and DNA repair, independent of immune phenotype. Leukemia 2010, 24:491-499.
70. Teslovich T.M., Musunuru K., Smith A.V., et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010, 466:707-713.
71. Illig T., Gieger C., Zhai G., et al. A genome-wide perspective of genetic variation in human metabolism. Nat Genet 2010, 42:137-141.
72. Fu J., Keurentjes J.J., Bouwmeester H., et al. System-wide molecular evidence for phenotypic buffering in Arabidopsis. Nat Genet 2009, 41:166-167.
73. Zhernakova A., van Diemen C.C., Wijmenga C. Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nat Rev Genet 2009, 10:43-55.
74. Cookson W., Liang L., Abecasis G., et al. Mapping complex disease traits with global gene expression. Nat Rev Genet 2009, 10:184-194.
75. Fehrmann R.S., Jansen R.C., Veldink J.H., et al. Trans-eQTLs reveal that independent genetic variants associated with a complex phenotype converge on intermediate genes, with a major role for the HLA. PLoS Genet 2011, 7. e1002197.
76. Musunuru K., Strong A., Frank-Kamenetsky M., et al. From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus. Nature 2010, 466:714-719.
77. Dimas A.S., Deutsch S., Stranger B.E., et al. Common regulatory variation impacts gene expression in a cell type-dependent manner. Science 2009, 325:1246-1250.
78. Gerrits A., Li Y., Tesson B.M., et al. Expression quantitative trait loci are highly sensitive to cellular differentiation state. PLoS Genet 2009, 5. e1000692.
79. Nica A.C., Parts L., Glass D., et al. The architecture of gene regulatory variation across multiple human tissues: the MuTHER study. PLoS Genet 2011, 7. e1002003.
80. Fu J., Wolfs M.G., Deelen P., et al. Unraveling the regulatory mechanisms underlying tissue-dependent genetic variation of gene expression. PLoS Genet 2012, 8. e1002431.
81. Li Y., Alvarez O.A., Gutteling E.W., et al. Mapping determinants of gene expression plasticity by genetical genomics in C. elegans. PLoS Genet 2006, 2. e222.
82. Manolio T.A., Bailey-Wilson J.E., Collins F.S. Genes, environment and the value of prospective cohort studies. Nat Rev Genet 2006, 7:812-820.
83. Stolk R.P., Rosmalen J.G., Postma D.S., et al. Universal risk factors for multifactorial diseases: lifelines: a three-generation population-based study. Eur J Epidemiol 2008, 23:67-74.
84. Li Y., Tesson B.M., Churchill G.A., et al. Critical reasoning on causal inference in genome-wide linkage and association studies. Trends Genet 2010, 26:493-498.
85. Lee S.H., Wray N.R., Goddard M.E., et al. Estimating missing heritability for disease from genome-wide association studies. Am J Hum Genet 2011, 88:294-305.
86. Yang J., Benyamin B., McEvoy B.P., et al. Common SNPs explain a large proportion of the heritability for human height. Nat Genet 2010, 42:565-569.
87. Yang J., Manolio T.A., Pasquale L.R., et al. Genome partitioning of genetic variation for complex traits using common SNPs. Nat Genet 2011, 43:519-525.
88. Dickson S.P., Wang K., Krantz I., et al. Rare variants create synthetic genome-wide associations. PLoS Biol 2010, 8. e1000294.
89. Anderson C.A., Soranzo N., Zeggini E., et al. Synthetic associations are unlikely to account for many common disease genome-wide association signals. PLoS Biol 2011, 9. e1000580.
90. Wray N.R., Purcell S.M., Visscher P.M. Synthetic associations created by rare variants do not explain most GWAS results. PLoS Biol 2011, 9. e1000579.
91. Visscher P.M., Brown M.A., McCarthy M.I., et al. Five years of GWAS discovery. Am J Hum Genet 2012, 90:7-24.
92. Zuk O., Hechter E., Sunyaev S.R., et al. The mystery of missing heritability: genetic interactions create phantom heritability. Proc Natl Acad Sci U S A 2012, 109:1193-1198.
93. Visscher P.M., Medland S.E., Ferreira M.A., et al. Assumption-free estimation of heritability from genome-wide identity-by-descent sharing between full siblings. PLoS Genet 2006, 2. e41.
94. Aitman T.J., Boone C., Churchill G.A., et al. The future of model organisms in human disease research. Nat Rev Genet 2011, 12:575-582.
95. Ashley E.A., Butte A.J., Wheeler M.T., et al. Clinical assessment incorporating a personal genome. Lancet 2010, 375:1525-1535.